{"DataElement":{"publicId":"2932643","version":"1","preferredName":"Patient Physical Examination Pregnancy Breast Feeding Contraindicated Ind-2","preferredDefinition":"the yes/no indicator related to a contraindicated assessment regarding pregnancy, nursing etc.","longName":"PT_PP_BF_CON_IND2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2932641","version":"1","preferredName":"Patient Physical Examination Pregnancy Breast Feeding Contraindicated","preferredDefinition":"information related to a contraidicated assessment regarding pregnancy, nursing etc.","longName":"PT_PE_PRE_BRF_CONT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2735628","version":"1","preferredName":"Patient Physical Examination","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.:A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual's health assessment.","longName":"C16960:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"489F7495-0E79-6CD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-17","modifiedBy":"ONEDATA","dateModified":"2008-03-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2932639","version":"1","preferredName":"Pregnancy Breast Feeding Contraindicated","preferredDefinition":"The condition of having a developing embryo or fetus in the body, after union of an ovum and spermatozoon. (Dorland, 27th ed):The nursing of an infant at the mother's breast.:To indicate the inadvisability of (a medical treatment, for example). (Dictionary.com)","longName":"C25742:C25596:C37933","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pregnancy","conceptCode":"C25742","definition":"The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Breast Feeding","conceptCode":"C25596","definition":"The nursing of an infant at the mother's breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Contraindicated","conceptCode":"C37933","definition":"State of a particular method of treatment, regimen, procedure, medication, etc. of being unsuitable and inadvisable, often because of a likely adverse reaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7109A4EB-E8E0-B011-E040-BB89AD436B43","latestVersionIndicator":"Yes","beginDate":"2009-08-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-13","modifiedBy":"ONEDATA","dateModified":"2009-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7109A4EB-E8F1-B011-E040-BB89AD436B43","latestVersionIndicator":"Yes","beginDate":"2009-08-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104993","version":"1","longName":"RTOG-1112","context":"NRG"}]}],"AlternateNames":[{"name":"PT_PP_BF_CON_IND2","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Any of the following:  Pregna","type":"Preferred Question Text","description":"Any of the following:  Pregnant women, Nursing women, Men or women of childbearing potential who are unwilling to employ adequate contraception","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Any of the following:  Pregnant women, Nursing women, Men or women of childbearing potential who are unwilling to employ adequate contraception throughout the duration of the study and for 12 weeks after treatment has ended","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Any of the following: Pregnant women Nursing women Men or women of childbearing potential who are unwilling to employ adequate contraception throughout the study and for men for up to 3 months after completing treatment","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Any of the following: Pregnant women, Nursing women, Men or women of childbearing potential who are unwilling to employ adequate contraception during this study and for up to 6 months after bevacizumab treatment has ended","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects.\r\n-\tPregnant women\r\n-\tNursing women\r\n-\tMen or women of childbearing potential who are unwilling to employ adequate contraception.\r\n","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown: Pregnant women, Nursing women, Men or women of childbearing potential who are unwilling to employ adequate contraception throughout the duration of the study and for 12 weeks after treatment has ended","url":null,"context":"CTEP"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"Any of the following: Women of childbearing potential and male participants who are unwilling to employ adequate contraception during protocol treatment and for at least 6 months following treatment.","url":null,"context":"CTEP"},{"name":"CRF Text 7","type":"Alternate Question Text","description":"Any of the Following: Pregnancy or women of childbearing potential not willing/able to use medically acceptable forms of contraception during protocol treatment or for at least 6 months following treatment.","url":null,"context":"CTEP"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"Any of the following: Pregnancy or women of childbearing potential and men who are sexually active with a woman of childbearing potential and not willing/able to use medically acceptable forms of contraception during protocol treatment and for at least 6 months following treatment.","url":null,"context":"CTEP"},{"name":"CRF Text 8","type":"Alternate Question Text","description":"Is the patient a pregnant or lactating women, or a sexually active male or female of childbearing potential who is not willing or able to use medically acceptable forms of contraception?","url":null,"context":"NRG"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7109B18C-31C1-47C8-E040-BB89AD4369C3","latestVersionIndicator":"Yes","beginDate":"2009-08-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-13","modifiedBy":"WISEM","dateModified":"2020-09-04","changeDescription":"Replaced VD Assessments Ind-2 2018320v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}